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Abstract
Background. Chronic pain (CP) is a major public health problem that affects one-third of the
population and can interfere with the activities of daily life and cause decreased quality of life.
Patients with CP have been increasingly prescribed opioids, contributing to the rise in the opioid
epidemic. Due to the long-term nature of CP, the use of opioids as the sole treatment for CP can
cause tolerance and increased dosages overtime which can lead to addiction and potentially
overdose. Therefore, CP treatment should include multimodal approaches to treatment to prevent
opioid misuse, opioid use disorder (OUD), and overdose. Multimodal treatments involve a
combination of pharmacological and nonpharmacological interventions. Objectives. In adult
patients (>18 years) with chronic pain treated with prescription opioids, how effective is a
multimodal treatment involving nonpharmacological and pharmacological interventions in pain
management and prevention of opioid use disorder compared to opioid treatment alone?
Methods. An online search of PubMed and CINAHL for peer-reviewed studies from 2015-2022
was conducted. Results. The electronic search yielded 632 articles. Twenty articles were
selected and assessed for information related to therapies in addition to opioid therapy that is
beneficial for the treatment of CP. Additional outcomes observed in some of the studies include
improved quality of life (QOL), sleep, pain relief, physical function, perceived stress, anxiety,
and depression. Conclusion. Systematic approaches to integrate multimodal CP management
and prevent opioid abuse and OUD are essential to promote optimal patient outcomes and
prevent opioid-related morbidity and mortality. The benefits of using multiple treatment
modalities for chronic pain reduction were found using all 20 studies in the review, with the most
beneficial patient outcomes seen when different treatment modalities were utilized.
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Introduction
Chronic pain affects over 100 million Americans, or one-third of the population, with 19
million adults experiencing severe chronic pain that interferes with activities of daily life or work
(National Institute on Drug Abuse, 2021; U.S Department of Health and Human Services, 2019).
According to the Center for Disease Control and Prevention (CDC) (2020), nearly half a million
Americans died from an opioid within the past two decades. In addition, eight to 12 percent of
people treated for chronic pain with opioids developed an opioid use disorder (National Institute
on Drug Abuse, 2021). The CDC released guidelines for prescribing opioids for chronic pain in
2016, stating that opioid therapy should be considered only if expected benefits will outweigh
risks to the patient and if opioids are used as treatment, then they should be combined with
nonpharmacologic therapy and nonopioid pharmacologic therapy as needed (Dowell et al.,
2016). Pain management is not a single approach but multimodal to effectively manage chronic
pain while improving quality of life (QOL) and preventing opioid misuse or abuse. Multimodal
chronic pain management following the biopsychosocial model of care addresses holistic aspects
of treatment for chronic pain, reducing the risk for opioid use disorder. This literature review will
address the multimodal interventions for managing chronic pain (CP) among individuals
concurrently treated with prescription opioids and evaluate their effectiveness in pain
management and prevention of opioid use disorder (OUD).

Background Information
Pain and Quality of Life
The type of pain looked at in this study is chronic pain that is not due to cancer, cancer
treatment, or end-of-life care. Chronic pain, a pain lasting for longer than three months, can
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cause a decreased QOL through added physical and mental stress. Physical stressors include
sleep disturbances, fatigue, trouble concentrating, and reduced appetite. Mental stressors include
decreased self-esteem, difficulty participating in social activities, anxiety, and depression.
(Mental Health America, 2020). Chronic is a complex and dynamic experience pain that can
result from a multitude of diseases, conditions, and injuries. There are three categories of chronic
pain: neuropathic pain, mixed pain, and nociceptive pain. Neuropathic pain is comprised of
neuralgias, peripheral neuropathy, neuropathic low back pain, post-stroke pain and pain relative
to spinal cord injuries (Clark et al., 2015). Mixed pain, which has nociceptive and neuropathic
components, includes chronic headache, fibromyalgia, phantom limb pain, complex regional
pain syndrome (CPRS), multiple sclerosis, myofascial pain syndrome, and skeletal muscle pain.
CPRS is a type of mixed chronic pain that occurs in the arm or leg after an injury, surgery,
stroke, or heart attack (Mayo Clinic, 2018). Nociceptive pain includes mechanical lower back
pain, rheumatoid arthritis, osteoarthritis, chronic inflammatory conditions, postoperative pain,
sickle cell crisis, and sports-related injury (Clark et al., 2015). Effective chronic pain treatment is
vital to promoting functionality and a quality of life.
Pharmacology
Opioids are valued for their effectiveness and quick onset of pain relief. The drug binds to
one of the three opiate receptors in the central nervous system: mu, kappa and delta. Mu
receptors are responsible for analgesia, physical dependence, respiratory depression, and
euphoria. When an opioid binds to a mu receptor to block pain signal transmissions, it releases a
large amount of dopamine (Dhaliwal et al., 2021). The dopamine surge reinforces the act of
taking the drug and leads to positive reinforcement, increasing the potential for addiction.
Prescription opioids used for chronic pain include natural opiates, semisynthetic opiates and fully
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synthetic opiates. Each of these classes has extended-release, long-acting and immediate acting
forms. Opioids have many side effects, including sedation, nausea, vomiting, constipation,
respiratory depression, euphoria, physical dependence, and tolerance (Medline Plus, 2018).
These drugs can cause physical and psychological addiction, leading to overdose and overdoserelated death.
Opioid Misuse
Misuse or abuse of opioids occurs when the prescribed drugs are used in a manner or dose
other than prescribed. Opioids that are commonly involved in OUD and opioid-related deaths are
Fentanyl, Dilaudid, Percocet and Morphine (National Institute on Drug Abuse, 2014). The
population that uses opioid prescriptions is predominantly older adults, but in this study we will
be looking at ages 18 years and older related to opioid use and abuse. The epidemic of opioid
abuse in the United States started in the 1990s when pharmaceutical companies aggressively
marketed sustained-release opioids claiming improved safety and less potential for addiction and
abuse compared to immediate-release preparations . This contributed to soaring rates of
prescribed sustained-release opioids. After widespread misuse of this medication occurred, it
became clear that these medications were more addictive than they had previously thought.
Stigma
Stigma related to living with pain and opioid use can prevent receiving quality care,
contributing to decreased mental health. Stigma is defined as a process wherein people with
particular social identities are labeled and devalued leading to discriminatory behavior against
people with the stigmatized identity (Tsai et al, 2019). Destimatizing addiction is vital and
involves classifying drug addiction as a "disease" instead of blaming the indivual for their
condition or weakness of character. Stigmatizing someone and their addiction can cause shame
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and guilt which cause people to want to escape their reality, artificially connect with others and
avoid negative feelings, all which fuel addiction and create a cycle of substance use (Patterson,
2021).
Multimodal Pain Management
Pain is of a complex nature and involves physical, psychological cognitive, and
behavioral aspects, underscoring the need for multidimensional treatment. Multimodal pain
management involves varied modes of treatment to manage and treat pain including
pharmacological and nonpharmacological components that consider the intensity and
pathophysiology of pain, the complexity of symptoms, the presence of comorbidity the social
context and the time this pain may persist (Arturo et al., 2019). Multimodal treatment can
involve many approaches: medications, physical rehabilitation, lifestyle changes, psychology,
advanced pain interventions, surgery, and complementary and alternative methods (Dale et al.,
2016). The Biopsychosocial Model of Care is used in multimodal pain treatment to describe pain
as a multidimensional and dynamic combination of physiological, psychological and social
factors that can impact each other (Meints et al., 2018).

Methods
Study Design
A systematic review of research was conducted on the types of interventions and
treatments completed in health care facilities in the multimodal management of chronic pain
among patients who have prescription opioids as their main pharmacological treatment. This
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review uses the PRISMA guidelines as a guide and contains articles retrieved from CINAHL,
PubMed, and MEDLINE.
Information Sources
One investigator independently searched CINAHL and PubMed databases. PubMed
Medical Subject Headings were used in electronic searches of the PubMed databases. CINAHL
subject headings were used in the CINAHL database. A keyword search did not produce further
articles for use in study.
Search Strategy
Based on the research questions, keywords used include "opioid use" and "chronic pain"
and "treatment". Results from PubMed and CINAHL contained search limitations including
publication date of 2015-2022, human subjects, the geography of the USA, and English
language. MeSH terms were used to define search terms for the PubMed database. Subject
headings were used to define search terms in CINAHL database. The flowchart in Figure 1
illustrates the search terms used in each database and the study selection process.
Inclusion/Exclusion Criteria
Articles that did not contain key elements from the research question were excluded.
Articles were included in the review if (a) the study was conducted on patients who experience
chronic pain that is treated with opioids; (b) examined the relationship between a multimodal
pain treatment and decreased incidence of OUD; (c); compared data from groups that used
nonpharmacological interventions in addition to opioid use to those that were prescribed only
opioid analgesics; and (d) was conducted on adults of all ages.
Data Extraction
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By scanning and observing the articles of their information on authors, publication year,
subject age, purpose of study and results, data from twenty articles was extracted. One researcher
reviewed the articles and compiled the data.
Figure 1

Search Results
The initial search yielded 632 results, 587 articles from PubMed and 45 from CINAHL.
Twenty-four duplicate articles were removed. Review of 496 article title and abstracts resulted
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in 112 articles for further eligibility evaluation. The remaining full text articles were reviewed
with criteria relative to the PICOT question, and 20 studies included in the literature review are
illustrated in Figure 1.
Results
Characteristics of Articles
Among the 20 studies that met inclusion criteria,, there were five systematic reviews, one
literature review, three cohort studies, two case-control studies, one retrospective case-control
study, four randomized controlled trials (RCTs), two descriptive qualitative studies, and two
integrative reviews of the literature. Findings from the articles is found in Table 2.

Figure 2
Table of Evidence
Reference

Cepeda, M.
S., Coplan,
P. M.,
Kopper, N.
W., Maziere,
J.-Y., Wedin,
G. P., &
Wallace, L.
E. (2017).
ER/LA
Opioid
Analgesics
REMS:
Overview of

Level of
Evidence

4

Hypothesis,
question, or
purpose

To evaluate
the impact of
the risk
evaluation
and
mitigation
problems on
opioid
misuse,
abuse and
death.

Design

Case Control
study

Sample
Methods &
Instruments
Procedures

Sample: outcomes
from July 2010
through June 2012
and outcomes from
July 2013 through
August or December
2014
Methods: used a
variety of outcomes
including the
number of
prescribers
completing a REMS-

Statistical Results
or Findings

The RADARS system
showed a 47%
decrease in the rates
of ER/LA opioid
abuse after REMS
implementation
while the NAVIPPRO
system found a
20.4% reduction;
The US Poison
control center
reported a 24.9%
decrease in the rates
of hospitalization or

Implications
or
Conclusions

Systems put
in place, such
as
implementing
a REMS, help
to decrease
the rates of
opioid use
disorders,
opioid
overdose or
opioid related
death.

10
Ongoing
Assessments
of Its
Progress
and Its
Impact on
Health
Outcomes. P
ain
Medicine, 18
(1), 78–85.
https://doi.o
rg/10.1093/
pm/pnw129

Chang, Y.,
4
Cassalia, J.,
Warunek,
M., &
Scherer, Y.
(2019).
Motivational
interviewing
training with
standardize
d patient
simulation
for
prescription
opioid abuse
among older
adults. Pers
pectives in
Psychiatric
Care, 55(4),
681–689.
https://doi.o
rg/10.1111/
ppc.12402
Denis, A. M. 5
(2019).
Managing

compliant CE
activity, assessment
of comprehension of
the medical guide
and patient
counseling
document by
patients, patient
satisfaction with
their access to
opioids

To examine
the effect of
motivational
interviewing
(MI)
education on
DNP
students’
learning
outcomes

Cohort Study

Care
management
of patients

Literature
review

Procedures:
outcomes from July
2010 through June
2012 were
compared to those
from July 2013
through August or
December 2014
Sample: 31 DNP
students
Methods: All 31 DNP
students completed
MI education
including a didactic
lecture, a role
playing exercise and
SP simulation then
completed a re- and
posttest about their
confidence, skills
and knowledge of
MI when treating
patients who abuse
opioids

Sample: Compilation
of information from
37 articles

death due to ER/LA
opioids after
implementation of
REMS.

After the MI
education and
simulation, students
indicated an
increase in
knowledge and
confidence
regarding MI in the
posttest.

Nurse
education
and practice
with MI can
help nurses to
be
knowledgeabl
e and
confident in
their MI
ability and be
able to
complete MI
with patients
who are
prescribed
opioids for
chronic pain
or for
patients who
have opioid
use disorder

During assessment
of the patient the
provider should

Preventing
and treating
OUD can be

11
Opioid Use
Disorder:
The Nurse
Practitioner
Addressing
the
Challenge.
MEDSURG
Nursing, 28(
5), 281–316.

Messina, B.
4
G., &
Worley, M.
J. (2019).
Effects of
craving on
opioid use
are
attenuated
after pain
coping
counseling
in adults
with chronic
pain and
prescription
opioid
addiction. Jo
urnal of
consulting
and clinical
psychology,
87(10), 918–
926.
https://doi.o

with OUD is
reviewed.

To determine
whether
behavioral
pain coping
strategies
would
facilitate
extinction of
the
conditioned
opioid use
response.

Methods: The
articles were used to
find information
relating to
management of
chronic pain when
opioids are involved
and how to prevent
or treat OUD.

Retrospective
case control
study

Procedures:
Information from
the articles was
compiled in this
systematic review to
talk about OUD,
managing opioid use
disorder and
nonpharmacological
interventions to
manage OUD.
Sample: 653
participants in Phase
1 and 360 in Phase
2; Individuals were
at least 18 years old
diagnosed with
current opioid
dependence, not
dependent on other
substances and had
no unstable medical
or psychiatric
conditions. In 74
participants received
standard medical
management and 74
received enhanced
medical
management
Method: Individuals
were randomized to
receive standard
medical
management (SMM)
or enhanced medical

perform a risk
assessment and
assess medical
history to assess for
OUD risk. Guidelines
by the American
Society of Addiction
Medicine should be
followed to provide
patient centered
care that promote
healthy lifestyles.

done through
risk
assessments
completed
before
providing
opioids or by
providing care
and use of
nonpharmaco
logical
treatment
modalities
such as
acupuncture
and
mindfulness
based classes
that
incorporate
CBT.

Pain and craving had
a strong positive
association, as a
greater time varying
pain significantly
predicted greater
craving. Treatment
week significantly
predicted craving,
with a reduction in
craving over time.
Craving was also
seen to have a
strong effect on
future opioid use.
All of these results
suggest craving
mediated the effect
of pain on opioid
use. Findings
indicate that greater
pain caused greater
subsequent use of
opioids and that the
risk of poor
treatment outcomes

Use of pain
coping
modules in
patient who
have known
opioid
dependence
can decrease
opioid
cravings.
Additional
module
repetitions
also increased
reductions in
opiate use
and craving.
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rg/10.1037/
ccp0000399

management
(EMM);
The SMM consisted
of physicians
assessing substance
use, craving and
BPN-NLX response,
recommending
abstinence and
referring patients to
self-help groups
while the EMM
consisted of a opioid
dependence
counseling delivered
by a trained
substance abuse or
mental health
counselor. The
opioid dependence
counseling involved
education and
discussion on one of
the 13 modules on
topics related to
pain, substance use
and coping. The pain
skills module
involved cognitive
behavioral coping
skills such as
relaxation, pacing,
engagement in
pleasurable activities
and cognitive
restructuring of pain
catastrophizing.
Weekly clinic visits
were used in SMM
and EMM to
complete
assessments, receive
medication refills or
adjustments and
attend counseling
sessions.

associated with
ongoing pain is due
to cravings. It also
found that
participants who
received the pain
coping module
reported reduced
opiate use and
coping with cravings
when they occur.

13

5
Fishman,
M. A., &
Kim, P. S.
(2018).
Buprenorp
hine for
Chronic
Pain: A
Systemic
Review. Cu
rrent pain
and
headache
reports, 22(
12), 83.
https://doi.
org/10.100
7/s11916018-0732-2

Describes the
role and
safety
advantages
of
buprenorphi
ne in the
treatment
of chronic
non-cancer
pain
compared
with other
potent opioid
analgesics.

Integrative
review of the
literature

1

To report the
current
evidencebased
medicine on
the use of
nonopioid
analgesics for
the most
common
noncancer

Systematic
Review

Nicol, A. L.,
Hurley, R.
W., &
Benzon, H.
T. (2017).
Alternative
s to
Opioids in
the
Pharmacol

Procedures: Opioid
use was assessed at
baseline and weekly;
reports from
participants of
current pain rating
and craving; time
varying covariates;
which participants
received the pain
coping modules and
the amount of times
the module was
repeated.
Sample: 12 studies
Methods: Articles
were assessed for
information related
to the use of
buprenorphine in
the treatment of
chronic pain.
Procedures: Studies
choses to be
assessed were high
quality unbiased
studies.

Sample: 271 studies
Methods: Studies
were selected with
the inclusion criteria
of adults 18 or over
with chronic pain
conditions, including
low back pain,
myofascial pain
syndrome,

The use of
buprenorphine in
the treatment of
chronic noncancer
pain can reduce pain
as well as reducing
the number of
opioid tablets
dispensed. If
buprenorphine is
used doses should
be titrated up and
patients should be
monitored closely.

This type of
treatment
types
including
buprenorphin
e can be
beneficial for
those that
have a high
risk of OUD.

Topical capsaicin
cream was found to
have a 30%
reduction in
numerical pain score
rating in those with
lower back pain and
was effective in the
reduction of pain
intensity when used
4 times a day in

In many of
the common
pain
conditions
people aged
18 and above
encounter,
there are
interventions
to help
relieve pain,

14
chronic pain
conditions

ogic
Manageme
nt of
Chronic
Pain
Syndromes
:A
Narrative
Review of
Randomize
d,
Controlled,
and
Blinded
Clinical
Trials. Anes
thesia and
analgesia, 1
25(5),
1682–
1703.
https://doi.
org/10.121
3/ANE.000
000000000
2426

Pullen, S.
D., Acker,

fibromyalgia,
postherpetic
neuralgia, painful
diabetic neuropathy,
radicular pain and
complex regional
pain syndrome. The
studies must have
investigated the
efficacy of nonopioid
medications when
compared to
placebo. The studies
had to be a
prospective,
randomized,
controlled, or
blinded design
Procedure:
Literature search
conducted in
Medline, Cochrane
Library and Scopus.
There was no
limitation on the
year of publication.
The search terms
used were the
specific chronic pain
condition couples
with the looked into
nonopioid
medication.

6

Is physical
therapy an
effective

Case Study
(qualitative)

Sample: 4
participants aged
from 31 to 65. All

patients with
postherpetic
neuralgia. The use of
capsaicin cream 4
times a day and
intradermal injection
of BoNT-A were both
shown to reduce
pain, improve
quality of sleep and
improve the quality
of life in patients
with diabetic
neuropathy. BoNT-A
when injected into
the lumbar spine
paraspinal muscles
provided superior
pain relief and when
injected
intradermally into
painful areas of the
skin of postherpetic
neuralgia patients it
was shown to
effectively reduce
pain intensity, sleep
disturbances and
reduce opioid use
for up to 12-16
weeks. In patients
with postherpetic
neuralgia the use of
a 5% lidocaine
patch.. A
pharmacological
intervention that
was effective in all
the pain conditions
with the exception
of MPS was the use
of ARI/opioid
medications such as
tramadol/acetamino
phen.
The average pain
report was 7.5/10
over the study. After

improve sleep
disturbances,
improve
quality of life
and even
reduce opioid
use. These
interventions
include use of
low or high
dose topical
capsaicin
cream, BoBTA injections
to the area of
pain and 5%
lidocaine
patches.

Use of PT
interventions
such as

15
C., Kim, H.,
Mullins,
M., Sims,
P.,
Strasbaugh
, H.,
Zimmerma
n, S., Del
Rio, C., &
Marconi, V.
C. (2020).
Physical
Therapy for
Chronic
Pain
Mitigation
and Opioid
Use
Reduction
Among
People
Living with
Human
Immunodef
iciency
Virus in
Atlanta,
GA: A
Descriptive
Case
Series. AID
S research
and human
retroviruse
s, 36(8),
670–675.
https://doi.
org/10.108
9/AID.2020
.0028

nonpharmac
ological
strategy to
mitigate
chronic pain
in people
living with
HIV?

participants
identified as African
American with two
female and two
male participants.
All had a noncancer,
chronic pain
diagnosis, had a
undetectable HIV
viral load and were
on chronic opioid
therapy. All had pain
in multiple locations
including lower
back, upper back,
neck, shoulder, hip
and knee. Pain
duration varied from
4 months to 4 years.
Methods: Eligible
participants were
referred by their
physicians and
further screened
through electronic
chart review. The PT
based interventions
were performed and
documented. PT
based interventions
used include
individualized home
PT
stretching/exercise
routines,
Transcutaneous
Electrical Nerve
Stimulation (TENS)
for 20 minutes on
painful area and
diaphragmatic/pace
d breathing. Each
person completed 510 PT sessions,
based on participant
needs, lasting 45
minutes in duration.

completion of the
interventions, two
participants had
complete resolution
of pain (0/10), one
had a final pain
report of 1/10 and
one had a final pain
report of 3/10. All
participants showed
a decrease in opioid
use. On the post-BPI
questionnaire all
participants
reported a decrease
in pain severity, a
decrease in pain
interference with life
activities and an
increase in pain
relief after the
intervention. Results
from the
postintervention SF36 indicate that
participants thought
they had
improvement in
general health, pain,
emotional wellbeing,
energy/fatigue and
role limitations due
to physical health.

stretching
and exercising
routines,
TENS and
diaphragmati
c/paced
breathing was
shown to
decrease pain
severity,
opioid use
and pain
interferences
with life
activities. The
PT
interventions
caused an
increase in
general
health,
wellbeing,
energy and
pain relief.
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These PT based
interventions were
completed before
administration of an
opioid analgesic.

1
MacLean
RR,
Armstrong
JL,
Sofuoglu
M. Stress
and opioid
use
disorder: A
systematic
review.
Addict
Behav.
2019
Nov;98:106
010. doi:
10.1016/j.a
ddbeh.201
9.05.034.
Epub 2019
Jun 1.
PMID:
31238237.

What is the
relation of
primary
appraisal of
stress to
opioid
craving,
opioid use
and OUD
treatment?

Systematic
Review

Procedure: Pre and
postintervention
data including: The
Brief Pain Inventory
(BPI), the 36-Item
Short Form Survey
(SF-36) for qualityof-life
measurements and
the HIV Opioid and
Pain Survey (HOPS)
to gather data, pain
experience and
opioid usage.
Sample: 21
manuscripts
included in the
review
Methods: Pubmed,
EMBASE, PsychINFO,
Scopus and
Cochrane Library
databases were
searched in January
2019 using the
Boolean search
terms opioid OR
opiate of
methadone OR
buprenorphine OR
naltrexone AND
stress OR
chronic+stress.
Studies were
included if
participants were
diagnoses with OUD,
appraised stress was
assessed using self
report with or
without

In the articles where
observed stress of
groups was
researched, they
found that stress
was higher after
exposure to triggers
such as drug cues,
negative affect and
thoughts about use.
Four studies
reported a positive
relationship
between appraised
stress and opioid
cravings, each study
making groups
complete a stressful
scenario than asking
about opioid
cravings They also
found that the
interaction of stress
and drug cues was
associated with
higher number of
cravings. There were
also environmental

Stress, when
looked at as
observed
stress or is
experimentall
y induced is
tied to higher
cravings for
opioids.
Participation
in cognitive
behavioral
therapy in
those with
previous
substance use
disorders,
was
associated
with lower
stress and
opioid use.

17
physiological or
neuroendocrine
measures and if
craving, use an OUD
treatment related
outcomes were
reported.

5
Zelfand E.
(2020).
Vitamin C,
Pain and
Opioid Use
Disorder. In
tegrative
medicine
(Encinitas,
Calif.), 19(3
), 18–29.

Can Vitamin
C spare those
in pain from
developing
OUD and
prevent and
treat OUD?

Integrative
Review of
Literature

Procedures:
Included
manuscripts were
separated into
categories: observed
stress,
experimentally
induced stress and
stress focused
interventions.
Sample: data taken
from personal
interviews, articles
and studies.
Methods: The data
from articles was
extracted and used
to look at the effect
of Vitamin C on the
treatment of chronic
pain relief and
opioid use disorder.
Procedures:
Included studies
were separated into
sections to address
certain clinical trials,
case reports,
experiences, and all
the effects of
Vitamin C in the
body.

factors related to
lower levels of
observed stress such
as being as home,
resting or taking
care of a child.

Vitamin C has been
found to have
analgesic benefit in
complex regional
pain syndrome
(CPRS) and may
reduce the risk of
developing CPRS
after an acute
fracture. Two people
who took 2 g of
sodium ascorbate
every 2 waking
hours were able to
lower opioid
dosages without
having any
withdrawal
symptoms. Vitamin
C has been shown to
modulate the
actions of glutamate
and dopamine, both
of which are
involved in opiate
tolerance and
withdrawal, to offset
addictive behavior.
Vitamin C deficiency
is associated with

Vitamin C can
help patients
comfortably
taper off
opioids and
prevent
opioid
tolerance and
dependency
when
administered
before a
surgery or
immediately
after an injury
that could
cause CRPS.
Vitamin C is
key in opiate
tolerance and
withdrawal
through it
affecting
glutamate
and
dopamine
and stress
due to its
effect on
cortisol levels,

18

Silva, M. J., 4
Coffee, Z.,
Yu, C. H., &
Martel, M.
O. (2021).
Anxiety
and Fear
Avoidance
Beliefs and
Behavior
May Be
Significant
Risk
Factors for
Chronic
Opioid
Analgesic
Therapy
Reliance
for Patients
with
Chronic
PainResults
from a
Preliminary
Study. Pain
medicine
(Malden,
Mass.), 22(
9), 2106–
2116.
https://doi.
org/10.109
3/pm/pnab
069

Are patients
with chronic
noncancer
pain (CNCP)
who
participate in
a chronic
opioid
analgesic
therapy
(COAT)
cessation
program able
to
successfully
cease COAT
and is COAT
reliance
motived by
anxiety and
fear-based
beliefs?

Case Control
Study

high cortisol levels,
and indicates poorer
health outcomes
indicating a need for
supplementation.
Sample: 109 patients A 90% success rate
with CNCP who has
of participant COAT
used daily COAT and cessation was
struggled to
revealed by all
maintain recent
participants by the
opioid cessation.
end of the program.
Elevated anxiety and
Methods:
fear based beliefs, as
Psychological
measured by the
questionnaires were Fear Avoidance
given to each patient Belief Questionnaire
at orientation,
(FAB), support COAT
comparing the
reliance and further
morphine milligram
continue CNCP.
equivalence of each Consistently
patient and gender
elevated scores from
of those who
the Fear Avoidance
successfully ceased
Belief Questionnaire
COAT use. Each
– The Physical
patient completed a Activity subscale
COAT cessation
(FAB-PA) were found
program. The
in patients who
program occurred
were unable to
once a week in a 6
cease COAT,
hour session for 10
suggesting fear
weeks. The cessation avoidance of
program included
physical activity
group cognitive
being significant for
behavioral therapy
COAT reliance. PCS,
that emphasized
TSK and COMM
pain coping skills
scores were
and mood
noncontributory to
regulation,
the data found.
complementary care
modalities and
individualized
medication
management. The A
panel urine drug
screen was
mandated at every
meeting. Many
scales were used

both of which
could prevent
opioid use
disorder.
In patients
with CNCP,
fear
avoidance
beliefs and
behavior, as
measured by
the FAB-PA,
plays a
significant
role in
unmanageabl
e COAT
dependence.
COAT
cessation was
seen in 90%
of the
participants in
the program
that included
CBT and pain
coping skills.
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including the Pain
Catastrophizing
Scale (PCS), Fear
Avoidance Beliefs
Questionnaire-Work
and Physical Activity,
Tampa Scale of
Kinesiophobia (TSK)
and Current Opioid
Misuse Measure
(COMM) to look at
fear avoidance
beliefs and behavior.

Zgierska, A.
E.,
Burzinski,
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What are the
benefits of
mindfulness
meditation

Randomized
Controlled
Trial

Procedures: Fishers
Exact Test and
Probability Plot was
used to determine
whether incoming
MME was related to
COAT cessation.
Penalized regression
was utilized to
identify potential
predictors of the
failed COAT
cessation based on
the phycological
questionnaires. After
the penalized
regression, Linking
and brushing was
used to determine
the relationships
between the
outcome and the
predictors. The
Decision Tree
Approach was used
to determine the
threshold of FAB-PA
and FAB-W scores
that conferred risk
of opiate cessation.
Sample: 35 patients
with CLBP under
long-term
treatments with

Compared with the
controls, the
meditation-CBT
improves the

The
statistically
significant
reduction in
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and cognitive
behavioral
therapy (CBT)
interventions
for patients
who are
treated with
opioids for
chronic low
back pain
(CLBP)?

daily opioids. 14
patients were
randomly assigned
to the control group
and 21 patients
were randomly
assigned to a
meditation CBT
group.
Methods:
Assessments and
evaluations of the
participants were
completed prior to
the start of the
intervention,
immediately post
intervention and 18
weeks post
intervention. Usual
care was provided to
all participants
including
pharmacotherapy
safety and
treatment progress
monitoring and
referral to specially
care and
complementary
therapy for pain
and/or mental
health. Participants
receiving the
meditation-CBT
intervention
completed a 2 hour
session per week for
8 weeks. Each
session focused on
topics relative to
meditation and CBT
that built on the
previous topics and
had a specific
therapeutic focus.

averaged pain
ratings across the
study, reducing the
pain score by 8% at
both 8 and 26
weeks, while the
pain scores in
control group
increased by 8% at 8
weeks and 10% at 26
weeks. Through The
Pain Psychophysical
Testing, the
relationship
between stimulus
intensity
(temperature) and
pain ratings was
found between the
two groups for both
pain intensity and
unpleasantness
indicating reduced
pain sensitivity in
the meditation-CBT
group. The C
reactive protein
levels in int eh
mediation-CBT
group were lower at
8 weeks compared
to the control. Those
that completed
home based formal
meditation had a
greater decrease in
pain ratings at 26
weeks.

pain severity
symptoms in
the
experimental
group
suggests
meditationCBT benefits
patients with
opioid treated
CLBP. There
was also a
reduction in
perceived
stress in the
group that
practice
mindfulness
and CBT.
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What
treatments
help adults
safely reduce
or stop
taking
opioids to
manage
chronic

Systematic
Review

Procedures:
Assessment and
evaluation data was
measured including
IMMPACT guidelines
with pain intensity
and CLPH-specific
function ratings
serving. During each
assessment session
three measures
were collected: self
reports of pain,
function, general
psychological and
physical health,
medication and
other substance use;
biomarkers (urine
specimens for
toxicology testing;
venous blood for
biomarkers); and
pain psychophysics.
Pain intensity was
assessed using a
Numerical Rating
Scale from 0-10.
Psychological health
was assessed by the
20 item Chronic Pain
Acceptance
Questionnaire
(CPAQ), the 15 item
Mindful Attention
Awareness Scale
(MAAS) and the 10
item Perceived
Stress Scale.
Sample: All 5 studies
were randomized
controlled trials
comparing opioid
users receiving an
intervention with a
control group
receiving treatment
as usual. Studies

Mindfulness
Oriented Recovery
Enhancement
(MORE) treatment
was effective in
lowering desire for
opioids and opioid
misuse as seen in
the study by

MORE
treatment
and
Therapeutic
Interactive
Voice
Response
(TIVR)
combined
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noncancer
pain?

included had more
than 10 participants.
Methods: Cochrane
Central Register of
Controlled Trials,
MEDLINE and
Embase were
searched to find
studies. Search
results were filtered
by two review
authors. Each study
was assessed for
random sequence
generation,
allocation
concealment,
blinding of outcome
assessment,
incomplete outcome
data, selective
reporting and size of
study. Primary
outcomes assessed
in each study were
opioid use and
adverse events.
Secondary outcomes
assessed were pain
intensity,
psychological
function and
physical function
Procedures: Risk
ratio was used to
establish statistical
difference. MantelHaenszel statistics
and report risk ratio
outcomes were used
for the analysis.
Inverse variance
methods in a
random effects
model was used to
analyze pain

Garland. The MORE
group also reported
significantly lower
pain intensity at post
treatment. In
another study, the
group that received
Therapeutic
Interactive Voice
Response through a
computer for four
months following
CBT reported a
significant decrease
in opioid use from
baseline, a decrease
in typical pain from
baseline and a slight
increase in physical
function when
compared to the
standard care
control group. This
group also had lower
depression scores
seen using the Beck
Depression Index. In
another randomized
control study, where
participants received
either real
electroacupuncture
or sham
electroacupuncture
the average pain in
pre and post test
treatment in the real
electroacupuncture
went from a 4.9/10
to a 4.2 out of 10
after 8 weeks. In the
study by Jamison,
substance misuse
CBT was used and
was seen to reduce
anxiety and
depression scores

with CBT
were both
effective in
lowering
opioid misuse
and pain
intensity.
TIVR and CBT
intervention
had effects on
psychological
functioning,
lowering
depression
and anxiety
scores.
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Is pain
rehabilitation
an effective
treatment for
chronic pain
and what are
its effects on
opioid
misuse risk?

Descriptive
Qualitative
study

intensity,
phycological
functioning and
physical functioning.
Sample: 126 patients
who were evaluated
for the Medical
University of South
Carolina (MUSC)
Pain Rehabilitation
Program (PRP) and
77 individuals met
inclusion criteria.
Methods: Every
patient completed
the MUSC PRP
program which
included CBT,
physical therapy,
occupational
therapy and medical
management
including opioid
tapering. Measures
of pain and pain
interference,
physical functioning,
psychological
functioning, health
related quality of
life, opioid use and
risk for opioid
misuse were
administered to
patients at pre and
posttreatment, at
Day 0 and Day 15.
Procedures: Pain
and pain
interference was
measured using the
Brief Pain Inventory
Short Form (BPI).
Physical functioning
was assessed using
the 6 minute walk

when compared to
the control group.

Average pain rating
decreased from pre
to posttreatment,
with BPI scores
going from 6.41 go
5.34. The
percentage of
patients who
reported their own
health status as
“poor” decreased
from 20% at
pretreatment to
1.7% at
posttreatment.
Feeling of anxiety
and depression
relative to pain
control and opioid
use decreased as
seen by the Brief
Symptom Inventory,
with anxiety
decreasing from
8.52 to 4.55 and
depression
decreasing from
9.50 to 3.60.
Physical functioning
increased from
1193.67 ft to
1505.25 ft
posttreatment as
measured by the
6MWT. 56.7% of
patients entered the
program with at
least on opioid
medication and at
discharge 88.3% of
patients left without
an opioid
prescription or any
remaining opioids.

Patients who
participated
in the 3 week
PRP reported
significantly
reduced
physical pain,
reduced pain
interference
with daily
activities,
improved
quality of life
and lowered
depression.
The majority
of patients
who entered
the MUSC
PRP on
opioids left
the program
having fully
tapered off
their opioid
medication.
Opioid misuse
risk was
significantly
reduced
among
patient who
entered on
opioids.
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Do
mindfulnessbased
interventions
reduce
chronic pain
and opioid
misuse in the
primary care
setting more
than
supportive

Randomized
Controlled
Trial

test (6MWT).
Psychological
functioning was
assessed using the
Brief Symptom
Inventory 18. Health
related quality of life
was assessed using
the Short Form 12
Health Survey.
Information of
patients opioid use
was gathered via a
combination of
patient report and
review of the South
Carolina Prescription
Drug Monitoring
Program (PDMP).
Risk for opioid
misuse was assessed
using the Current
Opioid Misuse
Measure.
Descriptive and
univariate analyses
were conducted to
determine sample
characteristics. Two
way paired t tests
were used to find
differences in mean
outcome scores
from pretreatment
to discharge.
Sample: 250 adults
with chronic pain
and opioid misuse
blindly randomized.
129 were
randomized to the
MindfulnessOriented Recovery
Enhancement
(MORE) group and
121 to the
supportive

For the patients that
continued chronic
daily opioid therapy,
there doses were
tapered significantly.
For patients that
entered the program
on opioids, their
mean scores on the
COMM were
significantly reduced
from 13.57 to 5.86.

At 9 months 36 of 80
participants (45%) in
the MORE group
were no longer
misusing opioid
compares with 19 of
78 participants in
the supportive
psychotherapy
group. 35 of 70
participants in the
MORE group
experienced greater

The
participants
who
completed
the MORE
intervention
had
statistically
significant
decreases in
opioid misuse
compared to
those
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psychotherap
y?

psychotherapy
group.
Methods: The group
receiving the MORE
treatment
completed training
in mindfulness,
reappraisal and
savoring positive
experiences and the
control group
received just
supportive group
psychotherapy. The
treatment occurred
over 8 weeks for a 2
hours group session
each week.
Outcomes were
collected at
baseline, after
treatment and at 3,
6 and 9 months of
follow up.
Procedures: Primary
outcomes were
opioid misuse
assessed by the Drug
Misuse Index and
pain severity and
pain related
functional
interference
assessed by subscale
scores on the Brief
Pain Inventory
through 9 months
follow up. Secondary
outcomes were
opioid dose,
emotional distress
and ecological
momentary
assessments of
opioid craving

reductions in pain
severity and 41 of 71
experienced
reductions in pain
related function
interference. 22 of
62 participants in
the MORE group had
decreased their
opioid dose by at
least 50% compared
with 11 of 69
participants in the
supportive
psychotherapy
group. Participants
in MORE group
experienced greater
decreases in
emotional distress
than the other
group.

receiving
supportive
therapy.
Participants in
the MORE
group also
has
improvement
in pain
severity and
pain related
functional
interference
and were able
to reduce
their daily
opioid dose
to a greater
extent than
participants in
the
supportive
therapy
group. The
effects from
MORE were
greater than
the effect size
of CBT and
the treatment
of
psychological
pain.
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Is the
integrative
medicine
(IM)
approach
including
Complement
ary
Alternative
Medicine
therapies
effective in
reducing
opioid use in
chronic pain
patients.

Systematic
Review

Sample: 23 studies
were chosen in this
study comprised of
eight randomized
controlled trials,
seven retrospective
studies, four
prospective
observational, three
cross sectional and
one quasi
experimental study.
Methods: An online
search of MEDLINE
and Emabse,
CINAHL, PubMed
and Allied and
Complementary
Medicine Database
for studies that are
randomized or nonrandomized
controlled trials and
retrospective studies
that include one or
more
Complementary
alternative medicine
(CAM) therapies
administered to
adults who had
chronic pain. 3
studies focused on
CBT, seven studies
examined cannabis,
two studied the
efficacy of
acupuncture, two
studied education
and opioid tapering
support, one
explored
mindfulness
oriented recovery
enhancement
(MORE), one
examined

All three studies
using CBT as an
intervention
reported significant
improvement in
pain, function and
phycological health.
The study using TIVR
showed decreased
pain and depression,
improved function
and coping and
reduced opioid
analgesic use. The
study assessing the
effectiveness of
MORE demonstrated
lower levels of pain
severity, functional
interference and less
desire for opioids
post treatment. The
study evaluating an
opioid tapering
support intervention
found that the
intervention group
saw more than
double the percent
reduction in
morphine equivalent
dose and improved
pain interference,
pain self efficacy and
perceived opioid
problems. Two
studies assessing the
impact of
acupuncture found
that pain medication
was reduced, better
pain relief and ability
to function was
achieved and quality
of life after one year
was improved.

CBT, TIVR,
MORE and
acupuncture
were all
interventions
that were
seen to
improve pain
severity,
opioid
craving,
physical
functioning,
and
psychological
health. Opioid
tapering
including
psychiatric
consultations,
motivational
interviews for
opioid
tapering and
education
sessions for
self
management
skills was
seen to
reduce doses
of opioid
medications
used for CP.
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therapeutic
interactive voice
response (TIVR)
after CBT and one
assessed the role of
physical therapy.
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What is the
role of
physiotherap
y practice in
chronic pain
management
at hospital
based
interprofessi
onal chronic
pain clinics
(HICPCs)?

Descriptive
qualitative
study

Procedure: To
critically appraise
the selected studies
the Mixed Methods
Appraisal Tool
(MMAT) was used.
Sample: ten
physiotherapists
who practiced in
pediatric and adult
HICPCS (n = 4
pediatric; n = 6
adult)
Methods: Each
physiotherapist
completed a semistructured interview
and demographic
questionnaire.
Procedures: The
interviews were
audio recorded and
transcribed
verbatim. Each
transcript was using
a codebook with
description of each
code using NVivo 12.
Potential themes
were discussed,
reviewed, and
defined by the
whole group.

Five themes were
constructed related
to physiotherapy
practice including (1)
contributing a
functional lens to
care; (2)
empowering
through pain
education; (3)
facilitating
participation in
physical activity and
exercise; (4)
supporting
engagement in selfmanagement
strategies; and (5)
implementing a
collaborative
approach to a whole
person care.
Contributing a
functional lens to
care includes
assessing how pain
affects the patient’s
life, creating goals
for quality life and
not one without pain
and to increase
functionality.
Empowering
through pain
education includes

A
collaborative
and whole
person
approach to
chronic pain
care in
patients is
seen to be
beneficial.
Tailored
approaches
are used in
aspects of
care related
to physical
activity, pain
education,
selfmanagement
strategies and
improving
functional
outcomes of
meaningful
activities.
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Can a
Harnessing
Online Peer
Education
(HOPE) social
media-based
support
group engage
patients at
risk for

Randomized
Controlled
Trial

Sample: 52
participants enrolled
in Facebook
community groups
(n = 25 in group
without the peer
role models
(control); n = 26 in
group with peer role
models)

empowering
patients to engage in
active CP
management
techniques, reducing
fear of movement
and changing beliefs
related to chronic
pain. Facilitating
participation in
physical activity and
exercise includes
providing exercises
related to patient’s
goals and gradually
increasing activity
tolerance over time.
Supporting
engagement in selfmanagement
includes teaching
patients how to
implement mindbody management
strategies and
support engagement
of behavioral selfmanagement
strategies.
Implementing a
collaborative
approach to a whole
person care includes
collaborating with
interprofessional
teams to establish
shared goals in
patient care.
13 out of the 25
participants (52%) in
the control group
provided a total of
45 posts or
comments while 19
out of the 26
participants (73%)
provided a total of
411 posts or

A HOPE peer
led social
media
community
can serve as
an effective
online tool to
engage
participants
with other
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misuse or
overdose to
discuss risk
reduction
strategies?

Methods:
Participants
engagement was
recorded in
Facebook
community groups
for 12 weeks for
each group. Engaged
participants were
defined as those
who whose,
commented or
reacted at least once
and were given an
engagement score.
Post and comment
were categorized
into the following
topics: Physical
health status,
mental health
status, pain, nonmedication
treatment,
medication
treatment,
substance use
disorder, coping and
social support.
Procedures: Grytics
software was used
to automatically
collect and
aggregate online
community
discussions for the
intervention and
control groups. It
provided data on
number and rates of
engagement as well
as most popular
topics in each group.
One researched
hand coded the
topics for each 4

comments.
Participants in the
intervention group
posted about the
following topics:
coping (33%),
physical health
status (32%).
Medication
treatment (27%),
pain (26%), nonmedication
treatment (24%),
mental health status
(21%) and social
support (19%). The
control group posted
about the following
topics: physical
health status (56%)
and medication
treatment (53%).

people also
experiencing
CP and are on
opioid
therapy. The
HOPE
intervention
group posted
ten times
more than
the control
group, had
higher levels
of
engagement
and talked
about a wide
range of
topics relative
to behavioral
interventions.
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Is the opioid
risk tool able
to
discriminate
between
patients with
and without
OUDs?

Cohort study

week period of the
12 week
intervention using a
modified grounding
theory. Chi square
test of
independence was
used for categorical
variables
(demographic
characteristics,
number of engaged
participants) and
two sample t test
were used to
compare difference
in continuous
variables (age,
engagement score)
Sample: 1178
patients with
chronic
nonmalignant pain
(CNMP) who were
receiving long term
opioid therapy
(LTOT). The control
group (n = 781) was
patients who did not
have an opioid use
disorder (OUD) while
the case cohort (n =
397) included
patients who were
treating CNMP with
LTOT and developed
a opioid
dependence.
Methods: This is a
secondary analysis
of baseline data
collected from a
cross sectional
naturalistic study.
Control patients
were recruited from
multiple ambulatory

Patients with OUDs
were likely to be
younger men,
unmarried, living
with fewer
household
members, have
lower education
levels, lower
socioeconomic
status, receive
disability benefits
and report higher
ORT total scores.
Patients with OUDs
were less likely to be
working full time
than those without.
Preadolescent
sexual abuse was
considered a poor
predictor for the
group with OUD
therefore it was not
weighted in the
study. Six of the nine
weighted items
loaded on the
strongest factor such

ORT
successfully
predicts the
risk of
developing an
OUD in
patients with
CNM, with
the 9-item
unweighted
version of
ORT found to
be superior.
The ORT can
be utilized to
assess the risk
of aberrant
drug related
behaviors in
patients being
considered
for LTOT
efficiently and
see if there
are currently
problematic
drug taking
behaviors in
the patient

31
pain and primary
care practices and
cases were recruited
from substance
abuse treatment
facilities. After
patients were
classified as having
OUD or not having
OUD, research
assistants
administered the
Mini International
Neuropsychiatric
Interview (MINI) and
Opioid Risk Tool
(ORT)
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What are the
benefits of
yoga among
military
veterans with
chronic low
back pain?

Randomized
Control Trial

Procedure: Patients
eligibility for this
study was assessed
using information
from the electronic
medical record.
Adults patients were
considered eligible if
they were Caucasian
and of European
descent, if they had
CNMP or
musculoskeletal or
neuropathic origin
persisting for 6
months or more in
duration and had
been receiving LTOT
for 6 months or
longer.
Sample: 150 military
veterans with
chronic lower back
pain (cLBP) (n = 75
receiving the yoga
intervention; n = 75
not receiving the
yoga intervention)

as family history of
substance abuse,
personal history of
substance abuse and
age.

that could be
a surrogate
for OUD.

Both study groups
had significant
reduction in RMDQ
scores after 12
weeks, however
after 6 months the
RMDQ score
continued to drop in
the yoga group and
increased toward

The yoga
intervention
was
confirmed to
be a safe
intervention
that can
reduce pain
an disability
among adults
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Methods:
Participants
randomized to the
yoga intervention
were scheduled to
attend a 12-week
yoga program
consisting of two 60minute, instructor
led yoga sessions
per week. Outcomes
were assessed via
patient self-report at
baseline, 6 weeks,
12 weeks and 6
months. Hatha yoga
was used and
consisted of physical
yoga postures,
movement
sequences and
regulated breathing.
Procedures: The
primary outcome
was change in the
Roland-Morris
Disability
Questionnaire
(RMDQ) score at 12
weeks. A secondary
outcome of interest
was pain intensity
assessed through
the short version of
the Brief Pain
Inventory.
Secondary outcomes
include the change
in pain intensity and
interference,
depressed mood,
physical and mental
quality of life,
fatigue, opioid
medication use and
other pain
treatments. The

baseline in the
control group. The
yoga participants
saw larger decreases
in mean pain
intensity after 12
weeks, but the mean
pain intensity went
back in the direction
of baseline at 6
months.

with cLBP.
This
intervention
was effective
in military
veterans,
which is a
population
that faces
more
challenges
related to
psychological
disorders and
substance use
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To explore
the overall
effectiveness
of
interdisciplin
ary intensive
outpatient
treatment
program in
adults with
chronic pain.

Systematic
Review

Wilcoxon rank sum
and Fisher’s exact
tests were used to
compare
demographic and
baseline clinical
variables between
study groups.
Sample: 13 studies
(1 RCT and 12
observational
studies)
Methods: Studies
included if they had
more than one
diagnosis related to
chronic pain. If the
study used group
interventions, it had
to cover pain
education, physical
therapy, behavioral
therapy and
functional exercise.
Studies that used
individual
interventions had to
include physical
therapy, functional
training or
behavioral therapy.
Outcome measures
had to include at
least two of the
following: pain
intensity, depressive
symptoms, pain
catastrophizing and
QOL.
Procedures: The
CMA was used to
perform all
statistical analyses.
Standardized mean
differences were

In adults with
chronic pain,
intensive outpatient
programs that
combine behavioral
and physical
interventions can
effectively reduce
pain intensity, pain
catastrophizing and
depressive
symptoms and
improve QOL post
intervention with
results maintained 6
months after
treatment.

Treatments
that focused
on a holistic
approach that
included
physical,
emotional
and
psychological
support can
reduce pain
intensity and
pain
catastrophizin
g in chronic
pain. QOL was
most
meaningfully
improved
after 6
months
posttreatmen
t.
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calculated using
Cohen’s d.

Summary of Studies
Pharmacological treatment
Out of the 200 medications prescribed for pain, the 20 that are opioids are
prescribed most frequently as they treat pain very well. Due to opioids addictive nature
and their high prescription volume, patients with CP may take medications for an
extended period of time, making them highly likely to have a dependency, addiction or
tolerance to these drugs. One drug that has been researched in terms of decreasing
frequency of addiction and withdrawal is buprenorphine. Originally used for Medication
Assisted Treatment for opioid abuse, Buprenorphine, an opioid receptor partial agonist,
has a unique pharmacological profile resulting in less withdrawal symptoms compared to
other opioid analgesics (Fishman et al., 2018).. Buprenorphine-naloxone (BUP-NLX)
therapy was used in a study related to opioid craving and pain coping skills. Participants
in this study received BUP-NLX in adjunct to other behavioral therapies, such as
cognitive behavioral therapy, and were seen to reduce cravings and future opioid use
when these therapies were combined (Chang et al., 2019).
Other pharmacological methods that have been tested for their efficacy in
reducing CP are muscle relaxers, anticonvulsants, NSAIDs, topical lidocaine patches,
topical capsaicin, and botulinum toxin type A. One expansive systematic review
researched the different types of chronic pain and which pharmacological interventions
reduced pain scores, pain intensity, opioid use, improved quality of sleep and QOL. The
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types of chronic pain researched included chronic lower back pain (cLBP), myofascial
pain syndrome, fibromyalgia, postherpetic neuralgia, painful diabetic neuropathy,
radicular pain, and complex regional pain syndrome. Muscle relaxers were seen to
provide significant pain relief for myofascial pain when compared to placebo.
Anticonvulsants were used as a potential treatment of postherpetic neuralgia,
painful diabetic neuropathy, and fibromyalgia. For postherpetic neuralgia, gabapentin
demonstrated effectiveness in reducing pain intensity, improving sleep interference and
mood compared to placebo in two studies. For painful diabetic neuropathy, pregabalin
was shown to reduce pain intensity, improve mood and reduce sleep interference and
gabapentin was effective in reducing pain intensity and improving mood, sleep, and
QOL. For pain from fibromyalgia, pregabalin was found to provide superior pain relief
and gabapentin was found to significantly improve average pain scores when compared
to the placebo group. NSAIDs were effective in cLBP, myofascial pain syndrome, and
radicular pain. Five studies found the NSAIDs naproxen, etoricoxib, valdecoxib, and
rofecoxib to be superior to the placebo in those with cLBP. One study found
indomethacin to be effective in the reduction of chronic radicular pain. Topical lidocaine
patches were effective in decreasing pain intensity for postherpetic neuralgia. Topical
capsaicin cream was used for cLBP, postherpetic neuralgia, and painful diabetic
neuropathy. Capsaicin cream was found to reduce numerical pain score by 30%. In
patients with postherpetic neuralgia, high dose capsaicin cream provided significantly
greater pain relief while low dose topical capsaicin was found to be effective with use
over a longer period of time in the reduction of pain intensity and improvement in sleep
interference in patients with painful diabetic neuropathy. Botulinum Toxin Type A
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(BoNT-A) was used in the treatments for cLBP, postherpetic neuralgia, and painful
diabetic neuropathy. In patients with cLBP, BoNT-A was found to provide superior pain
relief at 3- and 8-weeks posttreatment. For postherpetic neuralgia patients, BoNT-A
injected intradermally into painful skin was shown to be effective in the reduction of pain
intensity, improvement in sleep interference and reduction of opioid use. In patients with
painful diabetic neuropathy, intradermal injections of BoNT-A were shown to reduce
pain intensity, and pain sensory threshold and improve sleep interference and QOL.
Education
Providers, prescribers, and other clinicians are advised to follow the guidance of the CDC
on the prescription and administration of opioids for CP to prevent OUD. If health care
providers see patients with CP who are treated with opioids, the provider should be educated
on the risks and adverse effects associated with opioids and how to complete motivational
interviewing. The patients should also complete a risk and benefit analysis with their
provider, educating the patient on adverse effects and potential outcomes to see if opioid
therapy is the best treatment (Dowell et al., 2016).
Health care providers can implement a Risk Evaluation and Mitigation Strategy (REMS)
to assess the risk associated with opioids. The Food and Drug Administration created a
REMS for extended-release/long-acting opioids (ER/LA) to try to reduce serious adverse
outcomes related to inappropriate prescribing, misuse, and abuse of ER/LA opioids (Cepeda
et al., 2017). Currently, 24 companies that manufacture ER/LA opioids are REMS program
companies (RPC) and are all collaborating to operationalize this program (Cepeda et al.,
2017). Along with the REMS, the FDA revised patient education materials, including a onepage medication guide and a one-page counseling document, that should be provided to
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every patient that is dispensed an ER/LA opioid. In a case-control study, the effectiveness of
the REMS was assessed after 36 months of operation by looking at a variety of outcomes
important to this analysis: several prescribers completing a REMS continuing education (CE)
activity, evaluation of the knowledge and behaviors of prescribers, assessment of patient's
comprehension of the medication guide and patient counseling documents, patient
satisfaction with their access to opioids and surveillance monitoring of ER/LA opioid misuse,
abuse, overdose addiction and death (Cepeda et al., 2017). Opioid rates before and after
utilization of REMS were compared by using program data from the Researched Abuse,
Diversion and Addiction-Related Services (RADARS) and the National Addictions
Vigilance Intervention and Prevention Program (NAVIPPRO) that captured self-reported
information from patients entering abuse treatment programs. The program data from
RADARS found a 47% reduction and NAVIPPRO found a 20.4% reduction in the rates of
opioid abuse after REMS implementation. If health care providers prescribe opioids for the
treatment of CP a REMS should be implemented and patients should be educated and
counseled on the use of opioids as it is shown to reduce the rates of opioid abuse.
Education of healthcare providers on motivational interviewing (MI) can assist providers
with managing prescription opioid abuse, which can be seen in patients who use opioids for
CP. In a cohort study completed by Chang et al., 31 DNP students received MI education that
included a didactic lecture, a role-playing exercise, and a standard patient simulation. The
students completed pre and post-tests, with the greatest increase in MI confidence being from
preintervention to post didactic, indicating that their confidence was already built by the time
they completed their role-playing exercise and simulation. The students indicated in the
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debriefing section that they found value in the MI educational intervention and noted skill
acquisition.
Patients can benefit from pain education related to CP, the difference between hurt and
harm, and how to move through pain. In a descriptive qualitative study involving
physiotherapists who practiced in hospital-based interprofessional chronic pain clinics
(HICPCs), pain education is used to empower patients. Pain education focuses on the
biopsychosocial nature of CP with the goal of empowering patients to engage in CP
management strategies and should be integrated throughout every patient visit (Thacker et
al., 2021). By educating the patients on the meaning of CP and what is occurring in the body
the patients are more likely to change beliefs related to CP and be able to make educated
choices on pain relief. Pain education was shown to reduce patients' fear of movement and
improve confidence in patients to engage in active CP strategies, such as physical activity
(Thacker et al., 2021).
Screening and Monitoring
Screening tools can be used for predicting the risk of opioid misuse. The Current
Opioid Misuse Measure (COMM) is a self-report measure consisting of 17 items to
assess the frequency of abnormal medication-related behaviors and known risk factors for
opioid misuse over the past 30 days, with a score of 9 indicating opioid misuse risk
(Crouch et al., 2020). The Drug Abuse Screening Test is a valid self-reported assessment,
containing 10 yes or no questions to help health care providers assess for OUD (Denis,
2019). Assessing a patient's medical history can help a health care provider predict the
risk for OUD since conditions such as Hepatitis, HIV, and tuberculosis are linked to
OUD (Denis, 2019). A cohort study claimed that the Opioid Risk Tool (ORT) has
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improved predictive validity for assessing potential opioid-related aberrant drug-related
behaviors in patients who have chronic nonmalignant pain and are on long-term opioid
therapy (Cheatle et al., 2019). This tool was used along with a Mini-International
Neuropsychiatric Interview was used to exclude psychiatric disorders (Cheatle et al.,
2019). The ORT has 10 items that assess for family history of substance abuse, personal
history of substance abuse, age, history of preadolescent sexual abuse (in women only),
and presence of psychiatric diseases (attention deficit disorder, obsessive-compulsive
disorder, bipolar disorder, schizophrenia, and major depressive disorder) (Cheatle et al.,
2019).
Mental health screening tools can be used for patients using opioids for chronic
pain to assess for risk factors that facilitate potential abuse such as anxiety, depression,
and fear. One Case-Control Study administered psychological questionnaires to assess for
anxiety and fear-based beliefs and behavior (Silva et al., 2021). The screening tools used
in this study include the Fear Avoidance Beliefs Questionnaire (FABQ), Pain
Catastrophizing Scale (PCS), and Tampa Scale for Kinesiophobia (TSK) (Silva et al.,
2021). The FAB consists of The Work Subscale and the Physical Activity Subscale. A
higher score can correlate with an increased probability of current or future job loss,
disability, and social withdrawal. In the study, participants with a higher FAB pretest
score were unable to cease chronic opioid analgesic therapy. The PCS determines the
patient's level of catastrophizing thinking which is a risk factor for increased disability
length, pain intensity, and emotional distress. The TSK measures fear of movement,
injury, or reinjury with scoring that could indicate decreased physical performance and
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increased pain intensity, depressive symptoms, pain-related anxiety, and perceived
disability (Silva et al., 2021).
Behavioral Treatments
Behavioral Treatment such as pain coping strategies, cognitive behavior therapy
(CBT), Therapeutic Interactive Voice Response and group therapy can decrease opioid
cravings, and opioid dependence, allow tapering of opioid dosages, and decrease the
sensation of pain. In nine of the studies, behavioral treatments were included as a
treatment modality for CP.
Stress is a key factor in opioid cravings and inefficient coping mechanisms may
create an inability to handle multiple or intense stressors, thus turning to opioids. In
Maclean et al., there was a positive relationship seen between appraised stress and opioid
cravings. This was proven by four studies contained in Maclean et al. systematic review,
with all studies experimentally inducing stress in OUD groups and applying neutral stress
to other groups, then assessing opioid cravings after (Maclean et al., 2019). Stress in
individuals who previously had OUD can be defined as the summation of psychological
diagnoses, anxiety sensitivity, all potentially stressful life events, and reactivity to drugspecific cues (Maclean et al., 2019). Acute stress and chronic stress, related to repeated
exposure over time, are both found to be significant risk factors for opioid abuse. This
study also found that completion of cognitive behavior therapy in those with previous
substance use disorders was associated with lower stress levels and decreased opioid use
(Maclean et al., 2019). Learning effective coping mechanisms allows those that are
taking opioids to not turn to them as a way of coping or have opioid cravings after times
of stress. The teaching of coping strategies is also important when utilizing opioid
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tapering during certain treatment programs, such as pain rehabilitation programs (Crouch
et al., 2020). In a randomized controlled trial, a Harnessing Online Peer Education
(HOPE) online community was used to allow people to talk about pain, coping, physical
health status, mental health status, and social support (Young et al., 2019). The
intervention group joined a Facebook group message with peer role models that led these
discussions while the control group joined a Facebook group with no peer models
(Young et al., 2019). The intervention group posted 10 times more than the control group
and had higher levels of engagement. (Young et al., 2019). Their group served as an
effective online behavioral tool for patients to talk to others with similar problems and
learn from them. In a retrospective case-control study, a pain skills module was used to
test if it moderates the effects of craving on treatment outcomes (Messina et al., 2019).
The module involved a brief introduction to cognitive-behavioral coping skills for
managing physical pain including pacing, relaxation, engagement in pleasurable
activities, and cognitive restructuring of pain catastrophizing (Messina et al., 2019).
Craving was found to have a strong positive association with pain, future opioid use, and
poor treatment outcomes. In the weeks after subjects received the pain coping modules,
there was a reduced association between craving and future opioid use. It was also found
that the more module sessions completed, the greater attenuation of craving's effects on
opioid use (Messina et al., 2019).
Cognitive Behavioral Therapy (CBT) was used as an intervention in 6 studies.
CBT has been found to be effective in reducing opioid cravings, minimizing opioid
misuse risk, improving quality of life and improving psychological health. In one RCT,
CBT was used as a treatment method through the Medical University of South Carolina
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(MUSC) Pain Rehabilitation Program (PRP) (Crouch et al., 2020). This treatment
program also included physical therapy, occupational therapy, and medication
management such as tapering. Measures collected pre and post-treatment include pain
and pain interference, physical functioning, psychological functioning, health-related
QOL, opioid use, and risk for opioid misuse. After completing the program, feelings of
anxiety and depression relative to pain control and opioid use decreased as seen by the
Brief Symptom Inventory, with anxiety decreasing from 8.52 to 4.55 and depression
decreasing from 9.50 to 3.60 (Crouch et al., 2020). Participants also reported an increased
QOL and a meaningful improvement in self-perceived health status, causing patients to
be less likely to seek medical treatment and rely more on self-management skills acquired
in the PRP and patients having the ability to pursue a more mindful and accepting attitude
towards pain. One systematic review found that CBT used as an intervention to manage
CP and opioid use was effective in three studies that reported significant improvements in
pain, function, and psychological health (Hassan et al., 2020). A literature review
discussing an RCT that randomly assigned either CBT or methadone maintenance
treatment and monitored combined scores of the Addiction Severity Index (ASI) and
Perceived Stress Scale (PSS) attempted to determine if CBT can be effective in reducing
OUD (Denis, 2019). The group that received CBT had a decrease in their ASI and PSS
scores, seeing a decrease in weeks 12 and 26 of receiving CBT (Denis, 2019). Findings
suggested that CBT reduced opioid use, decreased stress, and improved employment
function among individuals with OUD (Denis, 2019). In a case-control study by Silva et
al, CBT that emphasized pain coping skills and mood regulation was used as an
intervention to attempt to cease chronic opioid analgesic therapy (COAT). The CBT
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intervention also involved complementary care modalities such as acupuncture,
mindfulness, biofeedback, and gentle motion. A 90% success rate or participant COAT
cessation by the end of the 10 weeks (Silva et al., 2021). In a RCT by Zgierska et al.,
participants with cLBP in the experimental group received a Mindfulness-CBT
intervention 2 hours per week for 8 weeks. Session topics built on previous topics and
included understanding the relationship between autopilot and pain, bringing mindfulness
into daily living, using mindfulness to cope, reducing vulnerability to pain triggered
autopilot reactions, understanding the importance of self-care and balance in life, and
using mindfulness to support life balance (Zgierska et al., 2016). Data were obtained at
baseline, 8 weeks and 26 weeks from self-reports, biomarkers and pain psychophysics.
The data indicated that the mindfulness-CBT group had reduced pain scores by 8% at 8
and 24 weeks while the pain scores in the control group increased by 8% and 10% at 8
and 24 weeks respectively (Zgierska et al., 2016). Each group completed pain
psychophysical consisting of the application of thermal stimuli. Differences in stimulus
intensity and pain ratings indicated reduced pain sensitivity and unpleasantness in the
meditation CBT group (Zgierska et al., 2016). In one systematic review, the use of an
intensive outpatient chronic pain treatment program including group or individual CBT,
pain education and stress, mood and pain self-management along with physical therapy
interventions was studied (Bujak et al., 2019). Studies contained in the systematic review
found that by helping individuals with chronic pain understand the biopsychosocial
components of pain through these interventions, individuals were able to modify their
thoughts and actions to improve QOL, emotional and social health and the reduction of
pain catastrophizing (Bujak et al., 2019). This study also found that short 2 to 4 week
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treatment programs had lasting behavioral changes, with the changes being maintained at
6 months posttreatment (Bujak et al., 2019).
One study contained in a systematic review used Therapeutic Interactive Voice
Response (TIVR) after CBT (Hassan et al., 2020). TIVR is an automated telephone-based
tool developed for maintenance enhancement following CBT and includes a daily selfmonitoring questionnaire, an instructional review of coping skills, prerecorded behavioral
rehearsals of coping skills, and monthly feedback methods from the CBT therapist
personalized to each patient's daily reports (Hassan et al., 2020). Results from the study
suggested that TIVR decreased pain and depression, reduced use of opioids, and
improved function and coping mechanisms (Hassan et al., 2020).
In a descriptive qualitative study, tapering in addition to CBT was successful as
56.7% of patients entering the program were on opioids and 88.3% of patients left with
no opioid prescription due to allowing tapering (Crouch et al., 2020). In a systematic
review, one RCT assessed an opioid taper support intervention for its efficiency in
lowering opioid doses in CP patients. The opioid taper support intervention consisted of
psychiatric consultation, motivational interviews for opioid tapering, and educational
sessions for self-management skills. The intervention group was able to achieve more
than double the percent reduction in opioid dose when compared to the control group
(Hassan et al., 2020).
Complementary alternative medicine
Complementary alternative medicine (CAM) was used as an intervention in 9
studies. CAM interventions used include acupuncture, yoga, mindfulness, and the use of
Vitamin C.
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In the systematic review from Eccleston et al., electroacupuncture was seen to
reduce pain ratings, with the average pain rating in the pre and post-test decreasing from
a 4.9/10 to a 4.2/10. The average pain rating in the control group that received sham
electroacupuncture went from 5.6/10 to 5.4/10, indicating a statistically significant
difference between the groups in the ratings of pain after the intervention (Eccleston, et
al., 2017). Two studies contained in a systematic review found that patients that received
at least 4 acupuncture treatments in one year reduced their opioid use, had better pain
relief, better ability to function, and improved QOL (Hassan, et al., 2020). The other
study assessing patients receiving electroacupuncture found that opioid use was
significantly reduced by 6 weeks of treatment (Hassan, et al., 2020). In a literature
review, Denis investigated the efficacy of acupuncture as an adjunctive treatment. In the
studies found, acupuncture was found to diminish opioid-associated anxiety and
depression (Denis, 2019).
Yoga as a mind-body approach to exercise was used in a descriptive qualitative
study and was used for the goal of exploring movement in a safe way to rewire and
remap a patient's nervous system (Thacker et al., 2021). Yoga as a self-management
strategy used by physiotherapists was seen to increase patients' sense of control over their
CP (Thacker et al., 2021). Other mind-body self-management techniques used include
belly breathing, muscle relaxation, body scans, and breath awareness scans (Thacker et
al., 2021). A RCT by Groessl et al. assessed the effects of a 12-week yoga program on
functional limitations and pain intensity in a military veteran population with cLBP at 6
weeks, 12 weeks, and 6 months. One group received the 60-minute hatha yoga
intervention twice a week, consisting of physical yoga postures, movement sequences
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and regulated breathing, and a home practice manual that recommended 15-20 minutes of
yoga practice on days that yoga sessions were not held while the other group continued
with usual pain treatments (Groessl et al., 2017). The yoga intervention group was seen to
have decreased in their Roland-Morris Disability Questionnaire and mean pain intensity,
especially after 6 months, though the magnitude of the reduction in pain was somewhat
small. There were problems seen with adherence to the yoga intervention. The median
number of classes attended was 15 of 24 classes, due to transportation and access issues
in this population, which could have contributed to the magnitude of health
improvements (Groessl et al., 2017).
Vitamin C has been found to be helpful in the tapering of opioids and the
prevention of opioid tolerance and dependency. Vitamin C was seen to prevent opioid
tolerance for use before specific surgeries and after injuries, such as wrist injury and
surgery, that may cause complex regional pain syndromes, when 500 mg was used daily
(Zelfand, 2020).
Mindfulness can be taught to patients with CP who are using opioids to decrease
opioid misuse and emotional distress related to opioid use. Mindfulness Oriented
Recovery Enhancement (MORE) combines mindfulness training, CBT, and principles
from positive psychology into integrative group therapy. A randomized controlled trial
assessed the effectiveness of MORE for patients with CP, completing assessments on
opioid misuse, pain severity, pain-related function interference, opioid dose, opioid
craving, and emotional distress post-treatment and at 3, 6, and 9-month follow up
appointments (Garland et al., 2022). At the 9-month follow up 36 of 80 (45%)
participants in the MORE group were no longer misusing opioids compared to 19 of 78
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participants in the supportive psychotherapy group (24.4%) (Garland et al., 2022).
Reductions in pain severity were seen in 35 of 70 (50%) participants in the MORE group
compared to 22 of 75 (29.3%) in the supportive psychotherapy group. 35% of the MORE
participants were able to decrease their opioid dose by at least 50% and saw greater
decreases in emotional distress. MORE interventions were seen to restructure reward
processing, enhancing neurophysiological responsivity to natural and healthy rewards
instead of drug-related rewards, helping with the long-term ability of those who have CP
to not misuse opioids. MORE treatment was also assessed in the literature review by
Eccleston et al., finding that participants who completed the MORE treatment had a
lower desire for opioids and self-reported lower opioid misuse at posttreatment. The
literature review completed by Denis surveyed mindfulness-based relapse prevention
(MBRP) therapies for managing OUD. MBRP incorporates CBT and consists of a series
of classes to raise patients' awareness of how to cope with relapse triggers and recognize
negative thinking that contributes to the risk of relapse (Denis, 2019). Using MBRP in the
plan of care was found to decrease the risk of relapse (Denis, 2019). In an RCT,
mindfulness techniques along with CBT were used in patients with cLBP (Zgierska et al.,
2016). Mindfulness techniques used were breath meditations, pain wave surfing
techniques, body scan meditations, mindful movement, SABER (Stop, Acknowledge,
Breathe, Expand, Respond) mini-meditation, Lovingkindness meditation, and formal
mindfulness sessions (Zgierska et al., 2016). These interventions all helped bring
attention to the breath, provided a nonjudgmental awareness of pain, engaged in present
moment acceptance of self and one's chronic pain, and enabled mindful awareness of
sensation (Zgierska et al., 2016). At the 8 and 26-week follow-up assessments, pain
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scores were decreased and pain acceptance scores were increased in the experimental
group, indicating the potential of CBT and mindfulness medication techniques to safely
reduce pain severity and sensitivity to pain (Zgierska et al., 2016).
Physical Treatments
Physical therapy or exercise was used as an intervention in 4 studies. In a
descriptive qualitative study, physiotherapists used a tailored approach to facilitate
participation in physical activity focusing on patient preferences and goals for exercise,
graded activity, and establishing a connection with community-based services (Thacker
et al., 2021). Recommendations for exercises are based on the patient's goals and focus
on gradually increasing activity tolerance through increasing the exercise parameters over
time (Thacker et al., 2021). Connecting patients to community-based services, such as
free access to a community center, can help with adherence to exercise long-term
(Thacker et al., 2021). In a qualitative study evaluating a Pain Rehabilitation Program
(PRP), physical and occupational therapy interventions were used along with CBT in
patients completing the 15-day program (Crouch et al., 2020). Patients who completed
the PRP reported a reduction in physical pain and pain interference with daily activities.
Physical functioning was seen to increase as measured by the 6 Minute Walk Test, with
the distance increasing from 1193.67 feet pretreatment to 1505.25 feet at discharge
(Crouch et al., 2020). In a cohort study, personalized stretching and exercise routines
were created along with transcutaneous electrical nerve stimulation (TENS), and various
pain coping strategies were used in treatment for four CP patients over five to ten, 45minute visits (Pullen et al., 2020). The average pre-intervention pain rating was a 7.5/10.
After the intervention two participants had a 0/10 rating, one had a 1/10 rating and one
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had a 3/10 rating, indicating a significant reduction in pain scores. Participants also
reported improvements in general health, emotional wellbeing, energy/fatigue, and role
limitations due to physical health (Pullen et al., 2020). In a
Transcutaneous electric nerve stimulation (TENS) is a non-invasive,
nonpharmacological treatment delivered to the patient through surface electrodes on the
site of pain (Pullen et al., 2020). In a cohort study by Pullen et al., TENS was used in CP
patients for 20 minutes on the painful area. Each patient also went through personalized
physical therapy. All participants reported improvements in physical function, QOL
related to pain, and general health in the postintervention assessment.

Discussion
Studies included in this review consistently acknowledged opioids as an integral
component of CP management while emphasizing the potential complications associated with
long-term opioid use. Risks associated with long-term opioid therapy include tolerance, physical
dependency, abuse, or OUD. Prevention of opioid abuse and OUD is a national public health
priority for reducing opioid-related morbidity and mortality. Studies addressed a variety of nonopioid and nonpharmacological approaches to safely manage CP in patients currently treated
with opioids while integrating other therapies to provide pain relief and prevent adverse
outcomes, such as OUD. Many of the studies used multiple interventions spanning different
categories for treatment of chronic pain, mostly combined with behavioral treatment, especially
pain coping strategies and CBT. Behavioral interventions are important to decreasing chronic
pain and reducing the risk of OUD as the feeling of pain is created in the brain and has
emotional, cognitive, and social components related to the intensity of pain felt and pain
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perception (Alshami, 2019). It was also found in many studies that when mindfulness is
combined with CBT it is more efficient in decreasing opioid misuse and cravings.
Healthcare providers face two significant challenges in treating CP—effective pain
management and preventing opioid-related morbidity and mortality. Nurses have an ethical
responsibility to minimize pain and suffering and promote optimal functioning and QOL.
Therefore, nursing education on multimodal treatment approaches is crucial to balancing pain
management efficacy and prevention of opioid-related risks, especially for nurses practicing in
settings with adults with CP. In addition, nurses should also be knowledgeable on appropriate
indications, use, monitoring for risks, and inappropriate use. Nurses can educate patients about
the mechanisms underlying their pain and the variety of non-opioid and nonpharmacological
treatments to optimize pain management and QOL.
More data is needed on each type of CP to see which nonpharmacological and
pharmacological interventions affect each type of CP. There is also more data needed on which
combination of pharmacological and nonpharmacological interventions is the most beneficial to
treating CP and preventing opioid use disorder in the patients that use opioids as an adjunct
therapy.

Limitations
Though all studies were knowledgeable and provided great insight into the multimodal
treatment interventions for CP, there are multiple gaps and limitations within the articles and the
information gathered that needs to be discussed. A limitation of the review includes not assessing
all types of medication used to treat CP and prevent opioid use disorder. There are also other
interventions that weren't used in this study but were seen in some of the study results.
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There were also limitations seen in some of the studies used in the literature review.
There was a major limitation in generalizability due to small sample sizes in one cohort study, as
it had 4 participants (Pullen et al., 2020). One of the studies about REMS relating to ER/LA
opioids had authors that were all employees of companies that market ER/LA opioid analgesics,
creating a conflict of interest. One randomized control trial related to mindfulness and CBT
therapies was not blinded for the participants or the study personnel, which could have
introduced a bias for both groups (Zgierska, 2016).
Conclusion
Systematic approaches to integrate multimodal CP management and prevent opioid abuse
and OUD are essential to promote optimal patient outcomes and prevent opioid-related morbidity
and mortality. The findings of this literature review demonstrate that utilization of multiple
treatment modalities in the management of CP improve patient outcomes. The most beneficial
treatment modalities among the studies were behavioral treatments, especially cognitive
behavioral therapy and pain coping education.
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